Publication: Enantioselective synthesis of 4-amino-3,4-dihydrocoumarins and their non-cyclic hydroxyester precursors: Biological evaluation for the treatment of glioblastoma multiforme.
No Thumbnail Available
Identifiers
Date
2022-09-01
Authors
Borrego, Lorenzo G
Recio, Rocío
Moreno, Nazaret
Chelouan, Ahmed
Álvarez, Eleuterio
Sánchez-Coronilla, Antonio
Caro, Carlos
Pearson, John R
García-Martín, Maria Luisa
Khiar, Noureddine
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The stereoselective addition of ethyl acetate enolate to the C═N bond of N-tert-butylsulfinylimines has been investigated in depth. A significant effect of the LHMDS amount and the N-sulfinylimine nature on the stereoselectivity of the process was observed. Conditions were found where sulfinylimines of differently substituted salicylaldehydes derivatives, ethyl acetate, and LHMDS afforded the corresponding addition products as a single diastereomer in good yields. The developed protocol was successfully applied to the first stereoselective synthesis of differently substituted 4-amino-3,4-dihydrocoumarin derivatives. Computational models confirmed the prominent role of the ortho aryl substituent in the stereoselectivity of the process. A significant and selective cytotoxic activity against Glioblastoma Multiforme (GBM) cancer line has been determined for the noncyclic hydroxy ester derivative.
Description
MeSH Terms
Humans
Glioblastoma
Stereoisomerism
Esters
Antineoplastic Agents
Glioblastoma
Stereoisomerism
Esters
Antineoplastic Agents
DeCS Terms
CIE Terms
Keywords
Enantiopure 4-amino-3,4-dihydrocoumarins, Glioblastoma multiforme, N-sulfinylarylimines, β-hydroxyesters